BridgeBio Pharma
Agent51Agent Readiness: 51/100. Top 25%. Measured by StartupHub.ai. Median 41.Trust95Data Trust: 95/100. Top 25%. Measured by StartupHub.ai. Median 61.Biopharmaceutical company developing transformative medicines for patients with genetic diseases and cancers.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
BridgeBio is a biopharmaceutical company focused on bringing meaningful medicines to patients quickly and safely. They develop and deliver treatments for genetic diseases, with a pipeline that includes approved medicines like Attruby® (acoramidis) and NULIBRY® (fosdenopterin), as well as investigational therapies for conditions such as Transthyretin Amyloidosis and Limb-Girdle Muscular Dystrophy. BridgeBio serves patients by advancing a diverse pipeline of therapeutic candidates from discovery through to commercialization.
Similar companies
A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Shares Pharmaceuticals, Healthcare
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, Pharmaceuticals
Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Shares Biotech, Pharmaceuticals
Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.
Shares Biotech, Pharmaceuticals
Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
Shares Biotech, Pharmaceuticals
A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
Shares Biotech, Pharmaceuticals
Key facts
- Website
- bridgebio.com
- Headquarters
- Palo Alto, United States
- Founded
- 2015
- Employees
- 875
- Business model
- B2B
Tech stack
Detected on bridgebio.com, last scanned 2 Nov 2026. Run your own scan
- Analytics
- Google Tag Manager
- CDN
- AWS CloudFront
- Hosting
- AWS
- Email provider
- Microsoft 365
- Cookie consent
- OneTrust
BridgeBio Pharma scores 67. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is BridgeBio Pharma trustworthy and reputable?
StartupHub's Data Trust & Reputation score for BridgeBio Pharma is 95 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does BridgeBio Pharma have?
BridgeBio Pharma has approximately 875 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for BridgeBio Pharma
